Nakia Brooks, PHYSICIAN ASSISTANT

NPI: 1013187301
Total Payments
$11,265
2024 Payments
$4,368
Companies
9
Transactions
28
Medicare Patients
371
Medicare Billing
$61,947

Payment Breakdown by Category

Consulting$6,250 (55.5%)
Travel$2,011 (17.8%)
Other$1,750 (15.5%)
Food & Beverage$1,056 (9.4%)
Education$198.95 (1.8%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $6,250 1 55.5%
Travel and Lodging $2,011 6 17.8%
Honoraria $1,750 1 15.5%
Food and Beverage $1,056 18 9.4%
Education $198.95 2 1.8%

Top Paying Companies

Company Total Records Latest Year
Exelixis Inc. $10,403 13 $0 (2024)
AstraZeneca Pharmaceuticals LP $218.19 2 $0 (2023)
Janssen Biotech, Inc. $165.75 3 $0 (2024)
Incyte Corporation $126.04 1 $0 (2023)
Ipsen Biopharmaceuticals, Inc $106.92 1 $0 (2024)
SANOFI-AVENTIS U.S. LLC $99.95 1 $0 (2021)
ABBVIE INC. $83.95 4 $0 (2024)
Daiichi Sankyo Inc. $42.11 2 $0 (2024)
Seagen Inc. $19.23 1 $0 (2022)

Payment History by Year

Year Amount Transactions Top Company
2024 $4,368 18 Exelixis Inc. ($4,153)
2023 $6,730 7 Exelixis Inc. ($6,250)
2022 $67.13 2 Janssen Biotech, Inc. ($47.90)
2021 $99.95 1 SANOFI-AVENTIS U.S. LLC ($99.95)

All Payment Transactions

28 individual payment records from CMS Open Payments — Page 1 of 2

Date Company Product Nature Form Amount Type
12/10/2024 Exelixis Inc. CABOMETYX (Drug) Food and Beverage In-kind items and services $101.79 General
Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC)
12/06/2024 Daiichi Sankyo Inc. Enhertu (Drug) Food and Beverage In-kind items and services $28.29 General
Category: ONCOLOGY
11/15/2024 Janssen Biotech, Inc. ERLEADA (Drug) Food and Beverage In-kind items and services $18.85 General
Category: Oncology
10/04/2024 ABBVIE INC. CREON (Drug) Food and Beverage In-kind items and services $16.15 General
Category: ENDOCRINOLOGY
07/03/2024 Exelixis Inc. CABOMETYX (Drug) Honoraria Cash or cash equivalent $1,750.00 General
Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC)
06/22/2024 Exelixis Inc. CABOMETYX (Drug) Travel and Lodging In-kind items and services $439.95 General
Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC)
06/22/2024 Exelixis Inc. CABOMETYX (Drug) Travel and Lodging In-kind items and services $439.95 General
Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC)
06/22/2024 Exelixis Inc. CABOMETYX (Drug) Travel and Lodging In-kind items and services $350.00 General
Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC)
06/22/2024 Exelixis Inc. CABOMETYX (Drug) Travel and Lodging In-kind items and services $350.00 General
Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC)
06/22/2024 Exelixis Inc. CABOMETYX (Drug) Travel and Lodging In-kind items and services $215.46 General
Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC)
06/22/2024 Exelixis Inc. CABOMETYX (Drug) Travel and Lodging In-kind items and services $215.46 General
Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC)
06/22/2024 Exelixis Inc. CABOMETYX (Drug) Food and Beverage In-kind items and services $90.00 General
Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC)
06/22/2024 Exelixis Inc. CABOMETYX (Drug) Food and Beverage In-kind items and services $90.00 General
Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC)
06/22/2024 Exelixis Inc. CABOMETYX (Drug) Food and Beverage In-kind items and services $55.28 General
Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC)
06/22/2024 Exelixis Inc. CABOMETYX (Drug) Food and Beverage In-kind items and services $55.28 General
Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC)
05/04/2024 ABBVIE INC. CREON (Drug) Food and Beverage In-kind items and services $31.16 General
Category: ENDOCRINOLOGY
05/01/2024 Ipsen Biopharmaceuticals, Inc Onivyde (Drug) Food and Beverage In-kind items and services $106.92 General
Category: Oncology
04/20/2024 Daiichi Sankyo Inc. Enhertu (Drug) Food and Beverage In-kind items and services $13.82 General
Category: ONCOLOGY
11/16/2023 Janssen Biotech, Inc. ERLEADA (Drug) Education In-kind items and services $99.00 General
Category: Oncology
11/09/2023 AstraZeneca Pharmaceuticals LP Food and Beverage In-kind items and services $117.41 General
10/20/2023 ABBVIE INC. CREON (Drug) Food and Beverage In-kind items and services $17.54 General
Category: ENDOCRINOLOGY
10/18/2023 Incyte Corporation PEMAZYRE (Drug) Food and Beverage Cash or cash equivalent $126.04 General
Category: Hepatology (Liver, Pancreatic, Gall Bladder)
10/11/2023 AstraZeneca Pharmaceuticals LP IMFINZI (Biological) Food and Beverage In-kind items and services $100.78 General
Category: Oncology
04/21/2023 ABBVIE INC. CREON (Drug) Food and Beverage In-kind items and services $19.10 General
Category: ENDOCRINOLOGY
02/08/2023 Exelixis Inc. Consulting Fee Cash or cash equivalent $6,250.00 General

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 2 100 199 $61,629 $17,207
2022 2 86 227 $70,729 $21,610
2021 2 102 172 $51,180 $15,855
2020 1 83 135 $32,085 $7,275
Total Patients
371
Total Services
733
Medicare Billing
$61,947
Procedure Codes
9

All Medicare Procedures & Services

9 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99215 Established patient office or other outpatient visit, 40-54 minutes Facility 2023 78 176 $56,224 $15,781 28.1%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2023 11 11 $2,585 $713.35 27.6%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 11 12 $2,820 $713.35 25.3%
99215 Established patient office or other outpatient visit, 40-54 minutes Facility 2022 72 212 $67,204 $20,676 30.8%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2022 14 15 $3,525 $933.90 26.5%
99215 Established patient outpatient visit, total time 40-54 minutes Facility 2021 65 128 $40,720 $13,045 32.0%
99214 Established patient outpatient visit, total time 30-39 minutes Facility 2021 37 44 $10,460 $2,810 26.9%
99214 Established patient office or other outpatient, visit typically 25 minutes Facility 2020 68 114 $27,150 $6,102 22.5%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 15 21 $4,935 $1,173 23.8%

About Nakia Brooks, PHYSICIAN ASSISTANT

Nakia Brooks, PHYSICIAN ASSISTANT is a Physician Assistant healthcare provider based in New Orleans, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/03/2008. The National Provider Identifier (NPI) number assigned to this provider is 1013187301.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Nakia Brooks, PHYSICIAN ASSISTANT has received a total of $11,265 in payments from pharmaceutical and medical device companies, with $4,368 received in 2024. These payments were reported across 28 transactions from 9 companies. The most common payment nature is "Consulting Fee" ($6,250).

As a Medicare-enrolled provider, Brooks has provided services to 371 Medicare beneficiaries, totaling 733 services with total Medicare billing of $61,947. Data is available for 4 years (2020–2023), covering 9 distinct procedure/service records.

Practice Information

  • Specialty Physician Assistant
  • Location New Orleans, LA
  • Active Since 03/03/2008
  • Last Updated 09/19/2022
  • Taxonomy Code 363A00000X
  • Entity Type Individual
  • NPI Number 1013187301

Products in Payments

  • CABOMETYX (Drug) $4,153
  • PEMAZYRE (Drug) $126.04
  • ERLEADA (Drug) $117.85
  • Onivyde (Drug) $106.92
  • IMFINZI (Biological) $100.78
  • JEVTANA (Drug) $99.95
  • CREON (Drug) $83.95
  • DARZALEX (Biological) $47.90
  • Enhertu (Drug) $42.11
  • PADCEV (Biological) $19.23

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Physician Assistant Doctors in New Orleans